Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 13 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2024 Filed Mar 13, 2024 22:11 UTC |
Calkins DanielChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 833 | Not disclosed Strike: $29.76 | Not disclosed |
DisclosureSEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 4 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 833 shares Expires 2030-04-01 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F5 · derivative.exercise_date: The canceled option was granted on April 1, 2020 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:11 UTC |
Calkins DanielChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,666 | Not disclosed Strike: $15.96 | Not disclosed |
DisclosureSEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 3 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,666 shares Expires 2029-12-20 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F4 · derivative.exercise_date: The canceled option was granted on December 20, 2019 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:11 UTC |
Calkins DanielChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 833 | Not disclosed Strike: $21.72 | Not disclosed |
DisclosureSEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 2 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 833 shares Expires 2029-06-21 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F3 · derivative.exercise_date: The canceled option was granted on June 21, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 12.5% of the shares underlying the option on each successive three month period after such date until the second anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:11 UTC |
Calkins DanielChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 631 | Not disclosed Strike: $43.32 | Not disclosed |
DisclosureSEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 631 shares Expires 2029-01-02 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F2 · derivative.exercise_date: The canceled option was granted on January 2, 2019 and provided for vesting as to 20% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 5.0% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fifth anniversary of the grant date. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 21:00 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 9,204 | $13.70 | $126,094.80 |
DisclosureSEC source: 0001104659-24-011598 · tm245463-1_4seq1.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,804 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.50 through $13.97, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:00 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 9,204 | $10.95 | $100,783.80 |
DisclosureSEC source: 0001104659-24-004453 · tm243349-1_4seq1.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,008 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Table I Column 4. is a weighted average price. These shares were sold in multiple transactions ranging from $10.75 through $11.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:03 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 6 | $8.50 | $51.00 |
DisclosureSEC source: 0001104659-24-002584 · tm242486-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,621 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. F2 · balance_after: Includes 277 shares of common stock purchased pursuant to the Issuer's 2018 Employee Stock Purchase Plan. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:04 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 25 | $8.08 | $202.00 |
DisclosureSEC source: 0001104659-23-130044 · tm2333888-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,350 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 20, 2023 Filed Dec 21, 2023 21:01 UTC |
Calkins DanielChief Financial Officer
|
SaleCommon Stock | 57 | $7.93 | $452.01 |
DisclosureSEC source: 0001104659-23-128190 · tm2333521-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,375 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 21:00 UTC |
Stuglik Brian MDirector
|
SaleCommon Stock | 274 | $7.73 | $2,118.02 |
DisclosureSEC source: 0001104659-23-127723 · tm2333364-1_4seq1.xml · nonDerivative · entry 2 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,450 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 21:03 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 130 | $7.73 | $1,004.90 |
DisclosureSEC source: 0001104659-23-127726 · tm2333364-3_4seq1.xml · nonDerivative · entry 2 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,212 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 21:01 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 183 | $7.73 | $1,414.59 |
DisclosureSEC source: 0001104659-23-127724 · tm2333364-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,916 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 21:00 UTC |
Stuglik Brian MDirector
|
SaleCommon Stock | 487 | $7.64 | $3,720.68 |
DisclosureSEC source: 0001104659-23-127723 · tm2333364-1_4seq1.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,724 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 21:03 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 284 | $7.64 | $2,169.76 |
DisclosureSEC source: 0001104659-23-127726 · tm2333364-3_4seq1.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,342 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 21:01 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 244 | $7.64 | $1,864.16 |
DisclosureSEC source: 0001104659-23-127724 · tm2333364-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,099 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| October 24, 2023 Filed Oct 26, 2023 20:28 UTC |
Calkins DanielChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $6.89 | $0.00 |
DisclosureSEC source: 0001104659-23-111753 · tm2329107-1_4seq1.xml · derivative · entry 1 Calkins Daniel · CIK 0001951861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-10-24 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of October 24, 2023 (the "Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 20:31 UTC |
Calkins DanielVice President of Finance
|
SaleCommon Stock | 5 | $7.30 | $36.50 |
DisclosureSEC source: 0001104659-23-108316 · tm2328003-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,432 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 25, 2023 Filed Sep 25, 2023 20:46 UTC |
Calkins DanielVice President of Finance
|
SaleCommon Stock | 25 | $9.40 | $235.00 |
DisclosureSEC source: 0001104659-23-103536 · tm2326760-1_4seq1.xml · nonDerivative · entry 2 Calkins Daniel · CIK 0001951861 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,437 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 21, 2023 Filed Sep 25, 2023 20:46 UTC |
Calkins DanielVice President of Finance
|
SaleCommon Stock | 232 | $9.31 | $2,159.92 |
DisclosureSEC source: 0001104659-23-103536 · tm2326760-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,462 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 19, 2023 Filed Sep 20, 2023 20:15 UTC |
Stuglik Brian MDirector
|
SaleCommon Stock | 274 | $9.84 | $2,696.16 |
DisclosureSEC source: 0001104659-23-102296 · tm2326467-1_4seq1.xml · nonDerivative · entry 2 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,211 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 19, 2023 Filed Sep 20, 2023 20:15 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 130 | $9.84 | $1,279.20 |
DisclosureSEC source: 0001104659-23-102298 · tm2326467-2_4seq1.xml · nonDerivative · entry 2 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,626 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 19, 2023 Filed Sep 20, 2023 20:15 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 183 | $9.84 | $1,800.72 |
DisclosureSEC source: 0001104659-23-102300 · tm2326467-3_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,343 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 20:15 UTC |
Stuglik Brian MDirector
|
SaleCommon Stock | 478 | $9.91 | $4,736.98 |
DisclosureSEC source: 0001104659-23-102296 · tm2326467-1_4seq1.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,485 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 20:15 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 278 | $9.91 | $2,754.98 |
DisclosureSEC source: 0001104659-23-102298 · tm2326467-2_4seq1.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,756 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 20:15 UTC |
Paterson DanDirector · President and CEO
|
SaleCommon Stock | 240 | $9.91 | $2,378.40 |
DisclosureSEC source: 0001104659-23-102300 · tm2326467-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,526 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:40 UTC |
Paterson DanDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $10.44 | $0.00 |
DisclosureSEC source: 0001104659-23-087889 · tm2322904-1_4seq1.xml · derivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-08-02 F2 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of August 2, 2023 (the "Option Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Option Grant Date until the fourth anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:40 UTC |
Paterson DanDirector · President and CEO
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-087889 · tm2322904-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,766 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of August 2, 2023 (the "RSU Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the RSU Grant Date until the fourth anniversary of the RSU Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 20:05 UTC |
Calkins DanielVice President of Finance
|
SaleCommon Stock | 5 | $8.02 | $40.10 |
DisclosureSEC source: 0001104659-23-079653 · tm2320874-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,694 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. F2 · balance_after: Includes 277 shares of common stock purchased pursuant to the Issuer's 2018 Employee Stock Purchase Plan. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 20:11 UTC |
Calkins DanielVice President of Finance
|
SaleCommon Stock | 26 | $8.17 | $212.42 |
DisclosureSEC source: 0001104659-23-075801 · tm2319848-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,422 F1 · shares: - The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:23 UTC |
Stuglik Brian MDirector · Chief Executive Officer
|
SaleCommon Stock | 275 | $10.30 | $2,832.50 |
DisclosureSEC source: 0001104659-23-073360 · tm2319280-1_4seq1.xml · nonDerivative · entry 2 Stuglik Brian M · CIK 0001716328 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,963 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:24 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 130 | $10.30 | $1,339.00 |
DisclosureSEC source: 0001104659-23-073362 · tm2319280-2_4seq1.xml · nonDerivative · entry 2 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,034 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:25 UTC |
Paterson DanPresident and COO
|
SaleCommon Stock | 183 | $10.30 | $1,884.90 |
DisclosureSEC source: 0001104659-23-073369 · tm2319280-3_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,766 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:23 UTC |
Stuglik Brian MDirector · Chief Executive Officer
|
SaleCommon Stock | 487 | $9.92 | $4,831.04 |
DisclosureSEC source: 0001104659-23-073360 · tm2319280-1_4seq1.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,238 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:24 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 283 | $9.92 | $2,807.36 |
DisclosureSEC source: 0001104659-23-073362 · tm2319280-2_4seq1.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,164 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:25 UTC |
Paterson DanPresident and COO
|
SaleCommon Stock | 244 | $9.92 | $2,420.48 |
DisclosureSEC source: 0001104659-23-073369 · tm2319280-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,949 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:31 UTC |
Tollefson Karin AnnaDirector
|
GrantStock Option (right to buy) · Derivative | 187,500 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-23-061414 · tm2315836-2_4seq1.xml · derivative · entry 1 Tollefson Karin Anna · CIK 0001976551 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2033-05-15 F1 · derivative.exercise_date: 125,000 of the stock options vest in twelve equal quarterly installments beginning each three successive month period following May 15, 2023 (the "Option Grant Date") until the third anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest). F2 · derivative.exercise_date: 62,500 of the stock options vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:32 UTC |
ROBERTSON MICHELLEDirector
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-23-061415 · tm2315836-3_4seq1.xml · derivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-05-15 F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:33 UTC |
JOHNSON JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-23-061421 · tm2315836-5_4seq1.xml · derivative · entry 1 JOHNSON JOHN · CIK 0001410781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-05-15 F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:35 UTC |
Rowinsky Eric KDirector
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-23-061427 · tm2315836-8_4seq1.xml · derivative · entry 1 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-05-15 F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:34 UTC |
Kauffman MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-23-061426 · tm2315836-7_4seq1.xml · derivative · entry 1 Kauffman Michael · CIK 0001364719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-05-15 F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:32 UTC |
Gagnon Robert E.Director
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-23-061419 · tm2315836-4_4seq1.xml · derivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-05-15 F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:36 UTC |
Bunn Paul A.Director
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-23-061429 · tm2315836-9_4seq1.xml · derivative · entry 1 Bunn Paul A. · CIK 0001868760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-05-15 F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:34 UTC |
Kapur AnilDirector
|
GrantStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-23-061424 · tm2315836-6_4seq1.xml · derivative · entry 1 Kapur Anil · CIK 0001730703 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2033-05-15 F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:30 UTC |
Calkins DanielVice President of Finance
|
SaleCommon Stock | 75 | $0.37 | $27.75 |
DisclosureSEC source: 0001104659-23-042752 · tm2311917-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,397 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 20:30 UTC |
Calkins DanielVice President of Finance
|
SaleCommon Stock | 378 | $0.42 | $158.76 |
DisclosureSEC source: 0001104659-23-037743 · tm2310686-1_4seq1.xml · nonDerivative · entry 1 Calkins Daniel · CIK 0001951861 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,472 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. F2 · balance_after: Includes 3,333 shares of common stock purchased pursuant to the Issuer's 2018 Employee Stock Purchase Plan. Read SEC document |
| March 20, 2023 Filed Mar 20, 2023 20:54 UTC |
Stuglik Brian MDirector · Chief Executive Officer
|
SaleCommon Stock | 3,508 | $0.43 | $1,508.44 |
DisclosureSEC source: 0001104659-23-034507 · tm239927-1_4seq1.xml · nonDerivative · entry 2 Stuglik Brian M · CIK 0001716328 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,112,736 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 20, 2023 Filed Mar 20, 2023 20:59 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 1,664 | $0.43 | $715.52 |
DisclosureSEC source: 0001104659-23-034515 · tm239927-3_4seq1.xml · nonDerivative · entry 2 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,399 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 20, 2023 Filed Mar 20, 2023 20:57 UTC |
Paterson DanPresident and COO
|
SaleCommon Stock | 2,339 | $0.43 | $1,005.77 |
DisclosureSEC source: 0001104659-23-034510 · tm239927-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,351 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 20, 2023 20:54 UTC |
Stuglik Brian MDirector · Chief Executive Officer
|
SaleCommon Stock | 6,276 | $0.40 | $2,510.40 |
DisclosureSEC source: 0001104659-23-034507 · tm239927-1_4seq1.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,116,244 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 20, 2023 20:59 UTC |
Gagnon Robert E.Director
|
SaleCommon Stock | 3,654 | $0.40 | $1,461.60 |
DisclosureSEC source: 0001104659-23-034515 · tm239927-3_4seq1.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 571,063 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.